Regulus Therapeutics
RGLS
#8339
Rank
A$0.17 B
Marketcap
$2.73
Share price
6.43%
Change (1 day)
36.51%
Change (1 year)

Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Volume in USD (price x number of shares), data since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$5.62 M3602.44%
2023A$0.15 M-85.22%
2022A$1.02 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
A$22.53 MA$43.31 M๐Ÿ‡ฌ๐Ÿ‡ง UK
A$3.41 MA$70.14 M๐Ÿ‡ซ๐Ÿ‡ท France
A$5.11 MA$63.51 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$13.08 MA$0.14 B๐Ÿ‡ฌ๐Ÿ‡ง UK
A$10.66 MA$50.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.86 MA$2.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$36.47 MA$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA